| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.072 | 0.2 |